Other headlinesMRI looks for genetic link to OCD
Medical Insight launches IT upgrade
Medical Insight has released a new version of its thin-client image viewer, called EasyViz 3.0. Enhancements include a 3D rendering engine, an image fusion application designed for cancer diagnostics, dedicated mammography functionality for screening and diagnostics, and a new patient study browser, which makes patient history data accessible to the clinician. offers tools to analyze patient images. The PC-based platform uses advanced adaptive streaming to provide instant access to DICOM-quality images.
MRI looks for genetic link to OCD
In what may be the world’s first study combining genetics and imaging, researchers at Wayne State University will use MRI to visualize brain processes they believe reflect the action of genes associated with obsessive-compulsive disorder (OCD). The researchers hope the $6 million project, funded by the NIH National Institute of Mental Health will lead to the discovery of “risk genes" for OCD. Wayne State University researchers will perform the imaging studies at Children's Hospital of Michigan. The team based at the University of Toronto/The Hospital for Sick Children will conduct the genetic studies. Their focus, glutamate, helps turn serotonin and other chemicals on and off in the brain.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.